Combination therapy with angiotensin-converting enzyme inhibitors and indapamide impairs glucose tolerance in Chinese hypertensive patients

References

• Neal B, MacMahon S, Chapman N. Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists’ Collaboration. Lancet. 2000;356:1955–1964.
   PubMed Web of Science ®Google Scholar
• Cushman WC, Ford CE, Cutler JA, Margolis KL, Davis BR, Grimm RH, . ALLHAT Collaborative Research Group. Success and predictors of blood pressure control in diverse North American settings: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich). 2002;4:393–404.
   PubMedGoogle Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, . Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252.
   PubMed Web of Science ®Google Scholar
• Mansia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, . European Society of Hypertension; European Society of Cardiology. 2007 ESH-ESC Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press. 2007;16:135–232.
   PubMed Web of Science ®Google Scholar
• Dunder K, Lind L, Zethelius B, Berglund L, Lithell H. Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: Population based cohort study. BMJ. 2003;326:681–686.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Reboldi G, Angeli F, Borgioni C, Gattobigio R, Filippucci L, . Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension. 2004;43:963–969.
   PubMed Web of Science ®Google Scholar
• Gillespie EL, White CM, Kardas M, Lindberg M, Coleman CI. The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes. Diabetes Care. 2005;28:2261–2266.
   PubMed Web of Science ®Google Scholar
• Palmer BF. Managing hyperkalemia caused by inhibitors of the renin–angiotensin–aldosterone system. N Engl J Med. 2004;351:585–592.
   PubMed Web of Science ®Google Scholar
• Labeeuw M, Pozet N, Zech PY, Hadj-Aissa A, Finaz de Villaine J, Laville M. Influence of acute administration of ramipril on the excretion of uric acid. Arch Mal Coeur Vaiss. 1987;80:870–874.
   PubMedGoogle Scholar
• Shargorodsky M, Boaz M, Davidovitz I, Asherov J, Gavish D, Zimlichman R. Treatment of hypertension with thiazides: Benefit or damage-effect of low- and high-dose thiazide diuretics on arterial elasticity and metabolic parameters in hypertensive patients with and without glucose intolerance. J Cardiometab Syndr. 2007;2:16–23.
   PubMedGoogle Scholar
• Saruta T, Ogihara T, Matsuoka H, Suzuki H, Toki M, Hirayama Y, . Antihypertensive efficacy and safety of fixed-dose combination therapy with losartan plus hydrochlo-rothiazide in Japanese patients with essential hypertension. Hypertens Res. 2007;30:729–739.
   PubMed Web of Science ®Google Scholar
• Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL. Thiazide diuretics, potassium, and the development of diabetes: A quantitative review. Hyhpertension. 2006;48:219–224.
   PubMed Web of Science ®Google Scholar
• Weidmann P. Metabolic profile of indapamide sustained-release in patients with hypertension: Data from three randomised double-blind studies. Drug Saf. 2001;24:1155–1165.
   PubMed Web of Science ®Google Scholar
• Leonetti G, Rappelli A, Salvetti A, Scapellato L. Long-term effects of indapamide: Final results of a two-year Italian multicenter study in systemic hypertension. Am J Cardiol. 1990;65:67H–71H.
   PubMed Web of Science ®Google Scholar
• Osei K, Holland G, Falko JM. Indapamide: Effects on apoprotein, lipoprotein, and glucoregulation in ambulatory diabetic patients. Arch. Intern. Med. 1986;146:1973–1977.
   PubMed Web of Science ®Google Scholar
• Gorden P. Glucose intolerance with hypokalemia. Failure of short-term potassium depletion in normal subjects to reproduce the glucose and insulin abnormalities of clinical hypokalemia. Diabetes. 1973;22:544–551.
   Google Scholar
• Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462–1470.
   PubMed Web of Science ®Google Scholar
• Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med. 2000;342:905–912.
   PubMed Web of Science ®Google Scholar
• Kinoshita M, Nakaya Y, Harada N, Takahashi A, Nomura M, Bando S. Combination therapy of exercise and angiotensin-converting enzyme inhibitor markedly improves insulin sensitivities in hypertensive patients with insulin resistance. Circ J. 2002;66:655–658.
   PubMed Web of Science ®Google Scholar
• Wu Z, Bao X. Effects of benazepril on insulin resistance and glucose tolerance in uremia. Clin Nephrol. 1998;50:108–112.
   PubMed Web of Science ®Google Scholar
• Sharma AM, Pischon T, Hardt S, Kunz I, Luft FC. Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis. Hypertension. 2001;37:250–254.
   PubMed Web of Science ®Google Scholar
• Messerli FH, Bell DS, Fonseca V, Katholi RE, McGill JB, Phillips RA, .; GEMINI Investigators. Body weight changes with beta-blocker use: Results from GEMINI. Am J Med. 2007;120:610–615.
   PubMed Web of Science ®Google Scholar
• Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17:961–9.
   PubMed Web of Science ®Google Scholar
• Despres JP, Lemieux I. Abdominal obesity and the metabolic syndrome. Nature. 2006;444:881–887.
   PubMed Web of Science ®Google Scholar
• Asmar RG, London GM, O’Rourke ME, Safar ME. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: A comparison with atenolol. Hypertension. 2001;38:922–926.
   PubMed Web of Science ®Google Scholar
• Elisaf MS, Theodorou J, Pappas H, Papagalanis N, Katopodis K, Kalaitzidis R, . Effectiveness and metabolic effects of perindopril and diuretics combination in primary hypertension. J Hum Hypertens. 1999;13:787–791.
   PubMed Web of Science ®Google Scholar
• Rowe JW, Tobin JD, Rosa RM, Andres R. Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism. 1980;29:498–502.
   PubMed Web of Science ®Google Scholar
• Sebastian JL, McKinney WP, Kaufman J, Young MJ. Angiotensin-converting enzyme inhibitors and cough: Prevalence in an outpatient medical clinic population. Chest. 1991;99:36–39.
   PubMed Web of Science ®Google Scholar
• Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann Intern Med. 1992;117:234–242.
   PubMed Web of Science ®Google Scholar
• Simon SR, Black HR, Moser M, Berland WE. Cough and ACE inhibitors. Arch Intern Med. 1992;152:1698–1700.
   PubMed Web of Science ®Google Scholar
• Imidapril and Benazepril Clinical Study Cooperation Unit. Comparative study of hypotensive efficacy and the cough occurrence of imidapril versus benazepril. Chin J Cardiol. 2004;4:304–307.
   Google Scholar
• Saruta T, Omae T, Kuramochi M, Iimura O, Yoshinaga K, Abe K, . Imidapril hydrochloride in essential hypertension: A double-blind comparative study using enalapril maleate as a control. J Hypertens Suppl. 1995;13:523–530.
   PubMedGoogle Scholar
• Dicpinigaitis PV. Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl):169S–173S.
   PubMed Web of Science ®Google Scholar